DGXNYSE
Quest Diagnostics Incorporated
$
0.000.00%
15-min delay
Open$
Prev Close$
Market Cap$21.61B
P/E (TTM)21.53
EPS$9.85
EarningsJul 28, 2026
DAY RANGE
$0.00$0.00
Key Statistics
Full Stats
Market Cap$21.61B
Enterprise Value$28.00B
P/E Ratio (TTM)21.53
P/S Ratio1.92
P/B Ratio2.94
Forward P/E
EPS (TTM)$9.07
EPS (FY)$9.85
Revenue (TTM)$11.28B
Profit Margin9.04%
Operating Margin14.58%
ROE14.17%
Debt/Equity0.87
Avg Vol (30d)976K
Beta (1Y)-0.14
Beta (3Y)0.29
Beta (5Y)0.60
Shares Out110.70M
Float110.15M
Dividend1.76%
Next EarningsJul 28, 2026
Short Interest
52-Week Range
$0.00
$164.65$213.50

Latest News
All
Company Info

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

SectorHealth Services
Employees55000
Phone973 520 2700
Address500 Plaza Drive
Secaucus, NJ, 07094
ISINUS74834L1008
500 Plaza Drive, Secaucus, NJ
Open in Maps
Analyst Consensus